CareDx financials
$64.02−0.90%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $379.8M | $333.8M | $280.3M | $321.8M | $296.4M | $192.2M | $127.1M | $76.6M | $48.3M | $40.6M |
| Gross profit | $256.6M | $224.1M | $178.3M | $209.6M | $199.0M | $129.1M | $81.6M | $43.6M | $27.0M | $19.5M |
| Gross margin | 67.6% | 67.1% | 63.6% | 65.1% | 67.1% | 67.2% | 64.2% | 56.9% | 55.8% | 48.0% |
| Operating income | -$30.8M | $40.8M | -$203.4M | -$77.2M | -$29.7M | -$22.5M | -$24.5M | -$21.4M | -$20.8M | -$37.3M |
| Net income | -$21.4M | $52.5M | -$190.3M | -$76.6M | -$30.7M | -$18.7M | -$22.0M | -$46.8M | -$55.5M | -$39.5M |
| Net margin | −5.6% | 15.7% | −67.9% | −23.8% | −10.3% | −9.7% | −17.3% | −61.1% | −114.8% | −97.1% |
| Diluted EPS | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 |
| EBITDA | -$10.1M | -$41.3M | -$92.7M | -$65.6M | -$17.8M | -$13.0M | -$17.4M | -$11.1M | -$14.2M | -$17.7M |
| Operating cash flow | $42.0M | $38.0M | -$18.4M | -$25.2M | -$19.3M | $33.4M | -$2.8M | -$5.0M | -$15.5M | -$16.1M |
| Free cash flow | $36.1M | $31.6M | -$26.7M | -$46.5M | -$32.9M | $26.3M | -$5.0M | -$7.1M | -$15.7M | -$16.6M |
| Diluted shares | 53.3M | 56.6M | 53.8M | 53.3M | 52.2M | 46.5M | 42.2M | 35.6M | 23.3M | 16.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.4M | $114.7M | $82.2M | $89.9M | $348.5M | $134.7M |
| Short-term investments | $111.8M | $146.0M | $153.2M | $203.2M | $0.00 | $90.0M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $413.2M | $491.1M | $466.8M | $543.0M | $566.6M | $368.5M |
| Total liabilities | $110.1M | $112.6M | $205.5M | $112.0M | $100.6M | $90.4M |
| Shareholders' equity | $303.1M | $378.4M | $261.3M | $430.9M | $466.0M | $278.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology